News Olumiant Approved for COVID-19 Treatment in Hospitalized Adults Publish Date May 11, 2022 The approval was based on data from the phase 3 ACTT-2 and COV-BARRIER studies.
Drugs in the Pipeline Tocilizumab Gets Priority Review for Treatment of Hospitalized COVID-19 Patients Publish Date April 5, 2022 The sBLA is supported by data from 4 randomized, controlled studies that evaluated tocilizumab for the treatment of COVID-19 in more than 5500 hospitalized patients.